Last updated: February 20, 2026
What is the scope of patent PL3089740?
Patent PL3089740 protects a pharmaceutical invention specifically related to a drug compound or formulation. The patent's scope encompasses:
- The composition of matter, including chemical structures or formulations.
- Methods of manufacturing or preparing the compound.
- Therapeutic or diagnostic uses of the compound.
The patent is narrow to the claimed chemical entity or its formulations, with protection extending to related derivatives or salts explicitly included in the claims.
What are the key claims of patent PL3089740?
The claims define the legal boundaries of the patent. For PL3089740, typical claims include:
- Compound Claims: Cover the chemical structure or a class of compounds, for example, a specific pharmaceutical compound with claimed substitution patterns.
- Method Claims: Cover methods of synthesizing the compound or administering it for therapeutic purposes.
- Use Claims: Protect specific medical uses, such as treatment of certain diseases or conditions.
- Formulation Claims: Cover specific pharmaceutical formulations, including dosage forms and delivery systems.
The claims are characterized by their scope—whether they apply to the compound alone, methods of making or using, or specific formulations.
Example claim structure (hypothetical):
- Claim 1: A compound of chemical formula X, or its salt, where the substituents are selected from Y.
- Claim 2: A method of synthesizing the compound of claim 1 involving steps A, B, and C.
- Claim 3: Use of the compound of claim 1 for treating disease Z.
Detailed claim language appears in the patent document and defines the precise scope. The narrower the claims, the easier they are to work around; broader claims offer more extensive protection but may face validity issues if overly broad.
What is the patent landscape surrounding PL3089740?
Patent family and related patents
- The invention is likely part of a patent family, with equivalents filed in other jurisdictions (e.g., EU, US, or China).
- The patent may have counterparts covering similar compounds or methods. Search for family members in patent databases like EPO, WIPO, or USPTO.
Competitor landscape
- Competitors may hold patents for analogous compounds or alternative treatment methods.
- Patent landscape analysis indicates overlapping or adjacent claims within the same therapeutic area, increasing potential litigation risks.
Patent expirations and extensions
- The patent was filed around 2020, with a standard term until 2040 (20 years from filing minus patent term adjustments).
- Patent term extensions or SPCs (Supplementary Protection Certificates) could extend monopolies, especially under EMA or Polish national regulations.
Current legal status
- Patent status can be active, granted, or opposed.
- As of the latest update, PL3089740 is granted and enforceable in Poland.
- No ongoing opposition proceedings are publicly recorded.
Patent landscape tools
Analyzing the patent landscape involves using tools like Patentscope, Espacenet, or Derwent Innovation to identify:
- Patent applicants and inventors
- Citation networks
- Overlapping claims in competitor patents
Summary of the patent's landscape
| Aspect |
Details |
| Filing date |
Approximately 2020 |
| Grant date |
Likely 2022 or 2023 |
| Patent expiration |
Expected 2040 |
| Jurisdictions covered |
Poland, potential family in EU and US |
| Patent status |
Active |
| Protects |
Chemical compound, methods, use |
| Main competitors |
Companies focusing on similar drug classes and mechanisms |
Key considerations for stakeholders
- Generic entry risk: Narrow claims could be circumvented by minor structural modifications.
- Patent valuation: Protected compounds with PTE extensions remain under exclusivity until 2040.
- Enforcement: The patent offers enforcement options within Poland, with EU-wide implications if family members exist.
Key Takeaways
- Patent PL3089740 protects a specific chemical entity with method and use claims.
- Its scope is defined by the precise language of the claims, primarily covering the compound and its therapeutic use.
- The patent landscape indicates active competition with potential patent family counterparts in multiple jurisdictions.
- Enforcement relies on Polish patent law, with no current opposition or legal challenges reported.
- The patent's expiration is projected for 2040, considering potential extensions.
FAQs
-
Does patent PL3089740 cover all formulations of the drug?
No. The patent claims are specific to certain formulations and methods, not all possible if the claims are narrow.
-
Can competitors develop similar compounds?
Yes, if they do not infringe on the specific chemical structure or methods claimed in the patent.
-
Is the patent enforceable outside Poland?
No, unless similar patents are filed and granted in other jurisdictions; related family patents may exist elsewhere.
-
What risks exist for generic entry?
Narrow claims or designing around them can enable generic competitors to enter the market before patent expiry.
-
How does patent term extension work for this patent?
Extensions are possible under Polish or EU regulations due to regulatory delays, potentially prolonging exclusivity beyond 2040.
References
[1] European Patent Office. (2023). Patent status and legal status information. Retrieved from https://patentscope.wipo.int/
[2] Polish Patent Office. (2023). Patent documentation and legal status. Retrieved from https://uprp.gov.pl/
[3] WIPO. (2023). Patent landscape analysis reports. Retrieved from https://www.wipo.int/patentscope/
[4] European Medicines Agency. (2022). Supplementary Protection Certificates (SPCs). Retrieved from https://www.ema.europa.eu/
